Meptazinol is an analgesic agent which combines agonist and antagonist opioid analgesic activity, and cholinergic analgesic activity (Bill et al., 1983) . Moreover, meptazinol has been shown to facilitate the action of acetylcholine which has been released by electrical stimulation of the isolated guineapig ileum (Stephens, Waterfall and Franklin, 1978) . The present study was designed to determine whether meptazinol modified neuromuscular transmission at the skeletal ncuromuscular junction in vitro and, if so, whether it could modify the action of neuromuscular blocking agents. To gain some preliminary information about the possible mechanisms underlying the pharmacological effects of meptazinol, comparisons have been made with neostigmine.
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MATERIALS AND METHODS
Male Sprague-Dawley rats were killed by a blow to the head and the two phrenic nerve-hemidiaphragm preparations (Bulbring, 1946) dissected out. The preparations were arranged for indirect stimulation by the application of rectangular electrical pulses to the phrenic nerve (0.5 ms, 0.1 Hz and a voltage greater than that required to produce a maximal twitch) and for direct stimulation (5 ms, 0.1 Hz and a voltage greater than that required to produce a maximal twitch) of the muscle. The muscle was set up at a resting tension of 4 g and the whole preparation was immersed in Krebs-Henseleit solution at 37 °C and bubbled with 5 % carbon dioxide in oxygen. Contractions of the muscle were recorded using an isometric transducer connected to a Grass 79C polygraph. Preliminary studies showed that meptazinol (as the hydrochloride) was difficult to wash off the preparation reliably and, thus, preparations were exposed to increasing concentrations of meptazinol hydrochloride in a cumulative manner. In order to determine whether prior exposure to low concentrations of meptazinol influenced the responses to subsequent exposures to high concentrations, some preparations were exposed to the high concentrations of meptazinol only.
SUMMARY
When either tubocurarine or suxamethonium was applied to the stimulated preparations a contact time of 5 min was used, followed by at least Preparations treated with ecothiopate iodide 96ugml~1 (an "irreversible" anticholinesterase) were left for a minimum of 30 min before the addition of any other drug. Meptazinol hydrochloride was added as single concentrations and then washed off. The contact time was sufficient to allow a maximum response to meptazinol-5-10 min.
Measurement of cholinesterase inhibition
The cholinesterase activity of homogenates of rat phrenic nerve-diaphragm preparations was assayed using the method described by Ellman and colleagues (1961) . Acetylthiocholine was hydrolysed by the cholinesterase in the tissue and the rate of hydrolysis was measured as the increase in the yellow colour produced by the interaction of thiocholine with the dithiobisnitrobenzoate ion.
Various concentrations of meptazinol hydrochloride or neostigmine methylsulphate were added to the cuvette and the inhibition of cholinesterase activity measured.
Unless otherwise stated, results are expressed as mean values ±SEM of not less than six experiments. Significance was assessed using the Student's t test. three washes over the subsequent 15 min. Concentration effect curves for either tubocurarine or suxamethonium were obtained before the administration of meptazinol hydrochloride or neostigmine methylsulphate, and then with increasing concentrations of the two agents. Preparations were pretreated with either meptazinol hydrochloride or neostigmine methylsulphate for 15 min before the addition of the neuromuscular blocking agents. Subsequently, the preparations were washed in Krebs-Henseleit solution containing the modifying agents. The EC S0 values for suxamethonium and tubocurarine in the presence of modifying agents were compared with EC 60 values obtained from time-matched control preparations not treated with meptazinol hydrochloride or neostigmine methylsulphate.
RESULTS
Meptazinol 2-32 ug ml" 1 caused an increase in the muscle contraction in response to indirect electrical stimulation (fig. 1) ; meptazinol 64 ug ml" 1 caused an initial increase in contraction followed by a decrease to undetectable values at 5 min. The muscle contraction in response to direct stimulation was unaffected by these concentrations of meptazinol.
In control preparations the EC 80 values for both tubocurarine and suxamethonium decreased slightly with time (table I). Meptazinol 0.5-2 ug ml" 1 significantly increased the EC 60 for tubocurarine, a result indicative of antagonism. This effect was lost with meptazinol 4 ug ml" 1 . A similar result was obtained when 4 ug ml" 1 was added to the tissue first. In contrast, meptazinol caused a concentration-dependent decrease in EC M for suxamethonium. Neostigmine methylsulphate had qualitatively similar effects on the neuromuscular blockade produced by tubocurarine and suxamethonium (table II) , although antagonism of tubocurarine still occurred with concentrations of neostigmine up to 2 ug ml" 1 . The mean cholinesterase activity of the homogenized male rat diaphragm was 1.33 ±0.02 mol litre" 1 min" 1 x 10"* per g of tissue. Both meptazinol and neostigmine caused a concentration-dependent inhibition of this activity (fig. 2) . The geometric mean EC M for meptazinol was 1.54 ( + 0.32, -0.26) ng ml" 1 and the geometric mean EC M for neostigmine was 2.97 ( + 0.53, -0.45) ng ml" 1 . In view of the significant anticholinesterase activity of meptazinol in the concentrations used, its effects on the indirectly stimulated rat phrenic nerve-diaphragm preparation were examined in preparations whose cholinesterase had been inhibited by ecothiopate iodide 96 ng ml" 1 (83 % inhibition on the homogenized preparation). In these circumstances meptazinol caused no increase in the tension of the muscle contraction, but caused significant decreases in tension in concentrations of 0.25 ng ml" 1 and 1 ng ml" 1 ( fig. 1) . The unexpected lack of response of the preparation to meptazinol 16 ng ml" 1 was a consistent finding. 
DISCUSSION
Meptazinol has been shown to antagonize the neuromuscular blocking effects of tubocurarine and to potentiate those of suxamethonium.
Qualitatively similar results were seen with neostigmine. The actions and drug interactions of neostigmine on the neuromuscular junction can be adequately explained on the basis of the inhibition of acetylcholinesterase at that site. However, neostigmine may also have presynaptic actions (Blaber, 1963) or direct acetylcholine-like properties (Riker and Wescoe, 1946) which contribute to its actions alone and in the presence of neuromuscular blocking drugs. This study has shown that meptazinol, like neostigmine, inhibits the cholinesterase present in the rat diaphragm muscle and that this occurred in the same concentration range for meptazinol as that used in the organ bath experiments. This suggests that anticholinesterase activity is important as far as the actions of meptazinol described in this paper are concerned.
Neostigmine inhibited the cholinesterase in the homogenized diaphragm in concentrations which were without obvious effects on neuromuscular transmission in the intact preparation. It is possible that the access of the highly polar neostigmine to cholinesterase is facilitated by homogenization. Tissue disruption may be less important for the lipid soluble meptazinol. However, not all of the effects of meptazinol seen in this study can be attributed to anticholinesterase activity, as high concentrations blocked neuromuscular transmission-an effect not seen with neostigmine in concentrations with comparable anticholinesterase activity. Furthermore, prior inhibition of cholinesterase by ecothiopate, a water soluble organophosphorous "irreversible" anticholinesterase agent (Taylor, 1980) , unmasked an inhibitory action of meptazinol on neuromuscular transmission at concentrations as low as 0.25 ug ml" 1 . No evidence has been gained from this study to determine whether the inhibitory actions of meptazinol are presynaptic or postsynaptic. It is tempting to dismiss the lack of effect of meptazinol 16 ug ml" 1 on the ecothiopate-treated preparation as an error in methodology. Unfortunately, neither fresh drug dilution nor new preparations produced any evidence that this was the case. An explanation of this finding must await a more detailed study of the actions of meptazinol on the neuromuscular junction.
The lack of antagonism of tubocurarine by meptazinol 4 ug ml" 1 may be the result of the intrinsic neuromuscular blocking activity of meptazinol overcoming its anticholinesterase activity.
